BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 32717056)

  • 21. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.
    Tang MS; Hock KG; Logsdon NM; Hayes JE; Gronowski AM; Anderson NW; Farnsworth CW
    Clin Chem; 2020 Aug; 66(8):1107-1109. PubMed ID: 32484860
    [No Abstract]   [Full Text] [Related]  

  • 22. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
    Kohmer N; Westhaus S; Rühl C; Ciesek S; Rabenau HF
    J Clin Virol; 2020 Aug; 129():104480. PubMed ID: 32505777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies.
    Nguyen NN; Mutnal MB; Gomez RR; Pham HN; Nguyen LT; Koss W; Rao A; Arroliga AC; Wang L; Wang D; Hua Y; Powell PR; Chen L; McCormack CC; Linz WJ; Mohammad AA
    PLoS One; 2020; 15(10):e0240076. PubMed ID: 33022019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Performance of Two SARS-CoV-2 Serologic Assays.
    Tang MS; Hock KG; Logsdon NM; Hayes JE; Gronowski AM; Anderson NW; Farnsworth CW
    Clin Chem; 2020 Aug; 66(8):1055-1062. PubMed ID: 32402061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
    Egger M; Bundschuh C; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():18-21. PubMed ID: 32485155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA.
    Stevens B; Hogan CA; Sahoo MK; Huang C; Garamani N; Zehnder J; Kurzer J; Pinsky BA
    J Appl Lab Med; 2020 Nov; 5(6):1307-1312. PubMed ID: 32761092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
    J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
    Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
    BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
    Erensoy S
    Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.
    Charlton CL; Kanji JN; Johal K; Bailey A; Plitt SS; MacDonald C; Kunst A; Buss E; Burnes LE; Fonseca K; Berenger BM; Schnabl K; Hu J; Stokes W; Zelyas N; Tipples G
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32665420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.
    Patel R; Babady E; Theel ES; Storch GA; Pinsky BA; St George K; Smith TC; Bertuzzi S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32217609
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2.
    Tollånes MC; Bakken Kran AM; Abildsnes E; Jenum PA; Breivik AC; Sandberg S
    Clin Chem Lab Med; 2020 Aug; 58(9):1595-1600. PubMed ID: 32598303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
    J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
    Risch M; Weber M; Thiel S; Grossmann K; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Renz H; Kohler P; Vernazza P; Kahlert CR; Paprotny M; Risch L
    Biomed Res Int; 2020; 2020():9878453. PubMed ID: 33224987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.